NCT06027086 2026-02-12DRP-104 (Glutamine Antagonist) in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 1/2 Recruiting27 enrolled